Baseline Therapeutics, Inc. ("Baseline"), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of ...

Certain of AIM’s leadership have indicated to the Company on a non-binding basis that they intend to participate in the Rights Offering, including Board member and Chief Executive Officer Thomas K.

Fake weight loss jab warning after number of illegal medicines seized in UK soars - ‘Deeply concerning’ new figures raise ...

Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

How weight-loss jabs are changing the way we spend money - Around 2.5 million people are currently estimated to be on ...

Bumrungrad International Hospital reveals alarming facts about excess weight and obesity among Thais, highlighting the ...

MBX plans to share the full 12-week dataset from Avail and one-year follow-up data at a medical conference in Q2 2026. An FDA ...

This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...

Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...

A 45-year-old woman presents with long-standing exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 years.

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes ...